Why Tattooed Chef Are Trading Lower By 47%; Here Are 20 Stocks Moving Premarket
$AGRX
$ALLR
$ATHX
$BACK
Biotechnology: Pharmaceutical Preparations
Health Care
Biotechnology: Pharmaceutical Preparations
Health Care
Gainers
- Micromobility.com Inc. (NASDAQ:MCOM) shares surged 60% to $0.18 in pre-market trading. micromobility.com recently reported a strategic realignment to strengthen its financial position and drive profitability.
- Fortress Biotech, Inc. (NASDAQ:FBIO) shares gained 38.2% to $0.76 in pre-market trading. Urica Therapeutics, a Fortress Biotech subsidiary company, recently disclosed topline data from the Phase 1 clinical trial evaluating dotinurad in healthy volunteers in the United States.
- IMAC Holdings, Inc. (NASDAQ:BACK) shares rose 35.9% to $0.1495 in pre-market trading. Theralink recently signed definitive merger agreement to be acquired by IMAC Holdings.
- FLJ Group Limited (NASDAQ:FLJ) shares rose 23.9% to $0.3680 in pre-market trading. The company said Mr. Lin Zhou has resigned as an independent director and a member of the audit committee of the Company, effective June 30, 2023.
- SQZ Biotechnologies Company (NYSE:SQZ) shares gained 20.7% to $0.3260 in pre-market trading after declining 11% on Friday.
- ENGlobal Corporation (NASDAQ:ENG) gained 16.2% to $0.4380 in pre-market trading. ENGlobal was recently granted 180-day extension by NASDAQ to regain compliance with minimum bid price rule.
- Athersys, Inc. (NASDAQ:ATHX) rose 14.9% to $1.00 in pre-market trading after gaining around 6% on Friday.
- Greenbrook TMS Inc. (NASDAQ:GBNH) shares climbed 14.4% to $0.7674 in pre-market trading. Greenbrook TMS recently announced the acceptance of Mr. Benjamin Klein's resignation from the board of directors of the Company.
- XPeng Inc. (NYSE:XPEV) gained 10.7% to $14.86 in pre-market trading after the company announced a significant increase in vehicle deliveries for June and the second quarter of 2023.
- Tesla, Inc. (NASDAQ:TSLA) rose 6.2% to $278.09 in pre-market trading after the company reported record deliveries numbers for the second quarter. The company’s quarterly deliveries came in at 466,140 units, compared to the company-compiled estimate of 446,823 units and the FactSet-compiled estimate of 445,000 units.
Losers
- Tattooed Chef, Inc. (NASDAQ:TTCF) fell 46.9% to $0.29 in pre-market trading after the company said that it intends to file for voluntary Chapter 11 Bankruptcy protection.
- Baudax Bio, Inc. (NASDAQ:BXRX) fell 22.2% to $0.91 in pre-market trading. Baudax Bio shares jumped around 125% on Friday after the company agreed to acquire TeraImmune in a stock-for-stock transaction.
- VBI Vaccines Inc. (NASDAQ:VBIV) fell 12.5% to $2.88 in pre-market. VBI Vaccines shares surged 75% on Friday after the company announced a $25.35 million contract from the Department of Health and Human Services.
- Agile Therapeutics, Inc. (NASDAQ:AGRX) fell 12.2% to $2.59 in pre-market trading after gaining around 13% on Friday. Agile Therapeutics named Scott Coiante to serve as Senior Vice President, CFO and Treasurer, effective Aug. 16.
- Bluejay Diagnostics, Inc. (NASDAQ:BJDX) fell 12.1% to $0.2311 in pre-market trading after jumping 30% on Friday.
- Bright Health Group, Inc. (NASDAQ:BHG) shares dropped 11.4% to $10.83 in pre-market trading. Bright Health shares gained around 12% on Friday after the company agreed to sell its California Medicare advantage business, Brand New Day and Central Health plan to Molina Healthcare for $600 million.
- TOP Financial Group Limited (NASDAQ:TOP) shares fell 8.7% to $8.57 in pre-market trading. TOP Financial shares gained over 20% on Friday after the company reported FY23 financial results.
- TC Biopharm (Holdings) Plc (NASDAQ:TCBP) fell 7.5% to $0.5012 in pre-market trading after dropping over 4% on Friday.
- Motorsport Games Inc. (NASDAQ:MSGM) fell 6.3% to $4.03 in pre-market trading. Motorsport Games recently posted better-than-expected first-quarter results.
- Allarity Therapeutics, Inc. (NASDAQ:ALLR) shares dropped 6% to $6.21 in pre-market trading. Allarity Therapeutics recently announced a reverse stock split of common stock.
Now Read This: Fear & Greed Index Remains In 'Extreme Greed' Zone After Nasdaq Records Best H1 Since 1983